St. Louis Encephalitis Virus

What It Is, Transmission, Signs, Symptoms, Diagnosis, and More

Author: Georgina Tiarks
Editor: Alyssa Haag
Editor: Emily Miao, PharmD
Editor: Kelsey LaFayette, DNP
Illustrator: Jessica Reynolds, MS
Modified: Jan 06, 2025

What is the St. Louis encephalitis virus?

St. Louis encephalitis (SLE) virus is an arbovirus (i.e., mosquito-borne virus) that is largely asymptomatic but can cause neurological disease. SLE virus is a single-stranded RNA virus that is a part of the Flavivirdae family and was first discovered during an epidemic in St. Louis, Missouri in 1933. Although the disease incidence is low, it can be found throughout North and South America. Cases can occur throughout the year, with the highest incidence during August.
An infographic detailing the background and transmission of the St. Louis encephalitis virus; including SLE virus molecule.

How is St. Louis encephalitis virus transmitted?

St. Louis encephalitis virus may be transmitted through the bite of an infected mosquito. The virus has a mosquito-bird-mosquito transmission cycle, in which birds act as hosts, allowing the virus to replicate without producing symptoms. In this cycle, mosquitos of the Culex genus are the vectors which transmit the virus when they feed. Humans and animals are considered dead-end hosts that become infected, meaning they cannot transmit the virus to each other.

Strategies to prevent virus transmission include utilizing mosquito repellent (e.g., DEET, permethrin), wearing protective clothing, and avoiding the outdoors during dawn and dusk. Using screens on windows or mosquito nets over beds can prevent mosquito bites while indoors. Towns can also eliminate standing water sources, which is where mosquitoes tend to breed, and spray insecticides into the air.

What signs and symptoms does St. Louis encephalitis virus infection cause?

St. Louis encephalitis virus infection causes a range of signs and symptoms, including a flu-like prodrome with fever, headache, fatigue, body aches, and nausea. A small subset of people infected will go on to develop signs of central nervous system dysfunction. Those who do can develop encephalitis (i.e., inflammation of the brain), meningitis (i.e., inflammation of the meninges), stiff neck, neurologic dysfunction, flaccid paralysis, confusion, dizziness, agitation, tremors, and coma. Immunocompromised individuals and older adults are more at risk of developing severe complications. The fatality rate can vary anywhere between 5 to 15%, with the highest rate in those 70 years or older. Children and young adults are more likely to have a mild disease course.

The incubation period from infection to symptom onset is between 5 to 15 days, though many individuals who are infected may remain asymptomatic. A study indicated that the likely ratio of subclinical to clinical cases is 300:1, meaning that many people who are infected with the virus have minimal to no symptoms. 

How is a St. Louis encephalitis virus infection diagnosed and treated?

Diagnosis of St. Louis encephalitis virus infection typically begins with blood work, such as a complete blood count (CBC), to assess for signs of infection (e.g., high lymphocyte count). Brain imaging, such as a CT scan or MRI, may be used to assess for signs of neurologic dysfunction. A lumbar puncture may also be necessary if meningeal signs, such as a stiff neck, are present. In cases of the SLE virus, a lumbar puncture with cytology may reveal a high opening pressure, lymphocytic pleocytosis, and an elevated cerebrospinal fluid (CSF) protein. An electroencephalography (EEG) can also be performed, which may reveal delta-wave activity with isolated spikes and diffuse slowing.

Once suspicion is high, targeted testing for the SLE virus may be performed. Serum and CSF testing can show the presence of the SLE virus, antigen, or nucleic acid using either a polymerase chain reaction (PCR) or immunohistochemistry. Immunoglobulin testing showing IgM antibodies using enzyme-linked immunosorbent assay (ELISA) to SLE virus may also indicate an SLE infection. If antibody titers show a four-fold increase, that can also indicate recent infection with the virus. 

There is no antiviral treatment available to treat St. Louis encephalitis. Treatment primarily involves supportive care with intravenous fluids and NSAIDs (e.g., ibuprofen) for pain and fever relief. 

What are the most important facts to know about the St. Louis encephalitis virus?

St. Louis encephalitis virus is a mosquito-borne illness that can cause neurologic dysfunction. Wearing protective clothing, using mosquito repellent, and minimizing outdoor activity during dusk and dawn can help to prevent mosquito bites that may transmit the St. Louis encephalitis virus. Although most people bitten by an infected mosquito remain minimally ill or asymptomatic, some individuals can also develop severe complications. Symptoms of St. Louis encephalitis may include fatigue, flu-like illness, headaches, encephalitis, meningitis, paralysis, and coma. The disease is generally milder in younger populations, while those with increased age and who are immunocompromised are at higher risk. SLE can be diagnosed with blood tests, imaging studies, and a lumbar puncture. There is no antiviral treatment for SLE, therefore, treatment is primarily supportive.

References


Curren EJ, Lindsey NP, Fischer M, Hills SL. St. Louis encephalitis virus disease in the United States, 2003–2017. Am J Trop Med Hyg. 2018;99(4):1074-1079. doi:10.4269/ajtmh.18-0420


Day JF. Predicting St. Louis encephalitis virus epidemics: Lessons from recent, and not so recent, outbreaks. Annual Review of Entomology. 2001;46(1):111-138. doi:10.1146/annurev.ento.46.1.111


Diagnostic Testing. St. Louis Encephalitis. Centers for Disease Control and Prevention. Published March 7, 2023. Accessed December 8, 2023. https://www.cdc.gov/sle/healthcare-providers/diagnostic-testing.html


Diaz A, Coffey LL, Burkett-Cadena N, Day JF. Reemergence of St. Louis Encephalitis virus in the Americas. Emerg Infect Dis. 2018;24(12):2150-2157. doi:10.3201/eid2412.180372


Reisen WK. Epidemiology of St. Louis Encephalitis Virus. In: Chambers TJ, Monath TP, eds. Advances in Virus Research. Vol 61. The Flaviviruses: Detection, Diagnosis, and Vaccine Development. Academic Press; 2003:139-183. doi:10.1016/S0065-3527(03)61004-3